An overview of ferroptosis in non-alcoholic fatty liver disease DOI Open Access

Shendong Wang,

Zhaojun Liu,

Jiafeng Geng

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2022, Volume and Issue: 153, P. 113374 - 113374

Published: July 11, 2022

Non-alcoholic fatty liver disease (NAFLD) is a public health problem associated with high mortality and morbidity rates worldwide. Presently, its complex pathophysiology still unclear, there no specific drug to reverse NAFLD. Ferroptosis an iron-dependent non-apoptotic form of cell death characterized by the iron-induced accumulation lipid reactive oxygen species (ROS), which damage nucleic acids, proteins, lipids; generate intracellular oxidative stress; ultimately cause death. Emerging evidence indicates that ferroptosis involved in progression NAFLD, although mechanism action NAFLD poorly understood. Herein, we summarize certain diseases, especially pathogenesis discuss potential therapeutic approaches currently used treat This review also highlights further directions for treatment prevention related diseases.

Language: Английский

Broadening horizons: the role of ferroptosis in cancer DOI
Xin Chen, Rui Kang, Guido Kroemer

et al.

Nature Reviews Clinical Oncology, Journal Year: 2021, Volume and Issue: 18(5), P. 280 - 296

Published: Jan. 29, 2021

Language: Английский

Citations

2034

The emerging role of ferroptosis in inflammation DOI Open Access

Yitian Sun,

Peng Chen,

Bingtao Zhai

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2020, Volume and Issue: 127, P. 110108 - 110108

Published: March 29, 2020

Ferroptosis is a newly discovered type of cell death triggered by intracellular phospholipid peroxidation that morphologically, biologically and genetically distinct from other types death. classified as regulated necrosis more immunogenic than apoptosis. To date, compelling evidence indicates ferroptosis plays an important role in inflammation, several antioxidants functioning inhibitors have been shown to exert anti-inflammatory effects experimental models certain diseases. Our review provides overview the link between inflammation; better understanding mechanisms underlying inflammation may hasten development promising therapeutic strategies involving address inflammation.

Language: Английский

Citations

572

Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death DOI Creative Commons

Anna Martina Battaglia,

Roberta Chirillo, Ilenia Aversa

et al.

Cells, Journal Year: 2020, Volume and Issue: 9(6), P. 1505 - 1505

Published: June 20, 2020

Ferroptosis is a new type of oxidative regulated cell death (RCD) driven by iron-dependent lipid peroxidation. As major sites iron utilization and master regulators metabolism, mitochondria are the main source reactive oxygen species (ROS) and, thus, play role in this RCD. is, indeed, associated with severe damage mitochondrial morphology, bioenergetics, metabolism. Furthermore, dysregulation metabolism considered biochemical feature neurodegenerative diseases linked to ferroptosis. Whether dysfunction can, per se, initiate ferroptosis whether function context-dependent still under debate. Cancer cells accumulate high levels ROS promote their metabolic activity growth. Of note, cancer rewiring often acquired sensitivity This strongly suggests that may act as an adaptive response imbalance constitute promising way eradicate malignant cells. Here, we review current literature on ferroptosis, discuss opportunities potentially use mitochondria-mediated strategy for therapy.

Language: Английский

Citations

416

Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy DOI
Shuangwen Li,

Lisi Zheng,

Jun Zhang

et al.

Free Radical Biology and Medicine, Journal Year: 2020, Volume and Issue: 162, P. 435 - 449

Published: Nov. 2, 2020

Language: Английский

Citations

299

ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis DOI Open Access
Bingqing Wang, Yue Wang, Jing Zhang

et al.

Archives of Toxicology, Journal Year: 2023, Volume and Issue: 97(6), P. 1439 - 1451

Published: May 2, 2023

Language: Английский

Citations

238

GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment DOI
Yi Liu,

Yicong Wan,

Yi Jiang

et al.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2023, Volume and Issue: 1878(3), P. 188890 - 188890

Published: March 29, 2023

Language: Английский

Citations

208

The emerging role of ferroptosis in intestinal disease DOI Creative Commons

Shu Xu,

Yao He, Lihui Lin

et al.

Cell Death and Disease, Journal Year: 2021, Volume and Issue: 12(4)

Published: March 17, 2021

Ferroptosis is a newly recognised type of regulated cell death (RCD) characterised by iron-dependent accumulation lipid peroxidation. It significantly distinct from other RCDs at the morphological, biochemical, and genetic levels. Recent reports have implicated ferroptosis in multiple diseases, including neurological disorders, kidney injury, liver cancer. Ferroptotic has also been associated with dysfunction intestinal epithelium, which contributes to several diseases. Research on may provide new understanding disease pathogenesis that benefits clinical treatment. In this review, we an overview its underlying mechanisms, then describe emerging role ischaemia/reperfusion (I/R) inflammatory bowel (IBD), colorectal cancer (CRC).

Language: Английский

Citations

179

Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions DOI Creative Commons
Valeria Consoli, Valeria Sorrenti,

Salvo Grosso

et al.

Biomolecules, Journal Year: 2021, Volume and Issue: 11(4), P. 589 - 589

Published: April 16, 2021

Heme-oxygenase is the enzyme responsible for degradation of endogenous iron protoporphyirin heme; it catalyzes reaction's rate-limiting step, resulting in release carbon monoxide (CO), ferrous ions, and biliverdin (BV), which successively reduced bilirubin (BR) by reductase. Several studies have drawn attention to controversial role HO-1, inducible isoform, pointing out its implications cancer other diseases development, but also underlining importance antioxidant activity. The contribution HO-1 redox homeostasis leads a relevant decrease cells oxidative damage, can be reconducted cytoprotective effects explicated alongside mechanisms involving genes like TIGAR (TP53-induced glycolysis apoptosis regulator), therapeutic functions heme main transformation products, especially has been shown effective on GSH levels implementation sustaining body's response stress. aim this review was collect most knowledge from literature, analyzing different perspectives try put forward hypothesis revealing yet unknown HO-1-involved pathways that could useful promote development new therapeutical strategies, lay foundation further investigation fully understand important system.

Language: Английский

Citations

177

Insights into N6-methyladenosine and programmed cell death in cancer DOI Creative Commons
Li Liu, Hui Li, Dingyu Hu

et al.

Molecular Cancer, Journal Year: 2022, Volume and Issue: 21(1)

Published: Jan. 28, 2022

Abstract N6-methyladenosine (m6A) methylation, the most common form of internal RNA modification in eukaryotes, has gained increasing attention and become a hot research topic recent years. M6A plays multifunctional roles normal abnormal biological processes, its role may vary greatly depending on position m6A motif. Programmed cell death (PCD) includes apoptosis, autophagy, pyroptosis, necroptosis ferroptosis, which involve breakdown plasma membrane. Based implications methylation PCD, regulators functional were comprehensively studied reported. In this review, we focus high-complexity links between different types PCD pathways, are then closely associated with initiation, progression resistance cancer. Herein, clarifying relationship is great significance to provide novel strategies for cancer treatment, potential prospect clinical application.

Language: Английский

Citations

176

The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis DOI
Naiara Santana-Codina, Ajami Gikandi, Joseph D. Mancias

et al.

Advances in experimental medicine and biology, Journal Year: 2021, Volume and Issue: unknown, P. 41 - 57

Published: Jan. 1, 2021

Language: Английский

Citations

174